Abstract |
Iotrolan was used in concentrations of 240 and 300 mg I/ml for indirect lymphography in a total of 70 patients, and permitted a diagnostic evaluation of the peripheral lymphatics in all cases. The contrast quality was found to correlate with the concentration used. The concentration of 300 mg I/ml Iotrolan was judged to provide the better contrast density and definition. Side effects were limited to transient local erythema and pain during the infusion in one patient and a protracted reaction resembling serum sickness in another patient ( Iotrolan 240 mg I/ml). Because of its excellent tolerance, Iotrolan is particularly suitable after subepidermal infusion for indirect lymphography, during which the local lymph drainage of cutaneous regions of interest can be evaluated.
|
Authors | H Partsch, C Stöberl, M Wruhs, B I Wenzel-Hora |
Journal | Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband
(Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd)
Vol. 128
Pg. 178-81
( 1989)
ISSN: 0178-4609 [Print] Germany |
PMID | 2568790
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Chemical References |
- Contrast Media
- Iodobenzoates
- Triiodobenzoic Acids
- iotrolan
|
Topics |
- Clinical Trials as Topic
- Contrast Media
(administration & dosage)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Humans
- Iodobenzoates
- Lymphedema
(diagnostic imaging)
- Lymphography
- Triiodobenzoic Acids
(administration & dosage)
|